Mercola | 21 November 2023
- “Immunization DNA” or iDNA is a novel class of gene therapy “vaccines” that encodes for the whole virus
- iDNA “vaccines” transcribe the full-length genomic RNA of the live-attenuated vaccine virus. The full-length viral RNA then initiates replication of live attenuated virus in the tissues of the vaccine recipient, resulting in an immune response
- The iDNA platform can be used to create vaccines in two different ways. You can either grow the iDNA in a culture to produce the vaccine in the conventional way, or you can inject the iDNA directly into the recipient and allow the body to produce the live attenuated virus internally
- The first human trials for an iDNA shot that codes for a live virus could begin as early as 2024
- In early April 2023, microbiologist Kevin McKernan reported he’d discovered DNA fragments in the mRNA shots made by Pfizer and Moderna, raising concerns about the possibility of genomic integration, autoimmune diseases and cancer. McKernan now reports having found a dose relationship between the load of DNA contamination and serious adverse events
idna-vaccines-pdf
Source: https://tinyurl.com/2v9dpt4d